By |

Profile

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its lead product is IMP321, which involves in clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trails, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia and derives most of the revenue from the sale of the products.

Contact Information

Website: www.primabiomed.com.au
Email: enquiries@immutep.com
Main Phone: +61 283157003
Address: 95 Pitt Street
Address 2: Level 12
State: NSW
City / Town: Sydney
Country: AUS
Postal Code: 2000

Issuer Information

Exchange: GREY
CEO: Marc Voigt
Employees: 19
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its lead product is IMP321, which involves in clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trails, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia and derives most of the revenue from the sale of the products.

Contact Information

Website: www.primabiomed.com.au
Email: enquiries@immutep.com
Main Phone: +61 283157003
Address: 95 Pitt Street
Address 2: Level 12
State: NSW
City / Town: Sydney
Country: AUS
Postal Code: 2000

Issuer Information

Exchange: GREY
CEO: Marc Voigt
Employees: 19
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.01 $ 0. (0.00%)
Last Price 0.01 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 0.01
Last Trade Volume 0 52 Wk Hi 0.02 52 Wk Low 0.01
Market Cap 33.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 3,380,000,000.00 EPS (TTM) 0.00 PE Ratio N/A Exchange Greys